MRSN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MRSN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.
Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.
Anna Protopapas | director, officer: President and CEO | MILLENNIUM PHARMACEUTICALS, INC., 40 LANDSDOWNE STREET, CAMBRIDGE MA 02139 |
Mohan Bala | officer: SVP, Chief Development Officer | C/O MERSANA THERAPEUTICS, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Tushar Misra | officer: Chief Manufacturing Officer | 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Brian Deschuytner | officer: Sr. VP, Finance & Product stgy | 840 MEMORIAL DRIVE, CAMBRIDGE MA 01776 |
Ashish Mandelia | officer: VP, Controller | 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Timothy B Lowinger | officer: Chief Scientific Officer | 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Alejandra Carvajal | officer: Chief Legal Officer | C/O CERULEAN PHARMA INC., 840 MEMORIAL DRIVE, 5TH FLOOR, CAMBRIDGE MA 02139 |
Ecor1 Capital, Llc | 10 percent owner | 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103 |
Arvin Yang | officer: Chief Medical Officer | 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Hack Andrew A. F. | director | 300 THIRD STREET, FIRST FLOOR, CAMBRIDGE MA 02142 |
Michael J. Kaufman | officer: Sr VP Chmistry, Man & Control | 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Allene M. Diaz | director | C/O ALLENA PHARMACEUTIALS, INC., ONEW NEWTON EXECUTIVE PARK SUITE 202, NEWTON MA 02462 |
Eva M. Jack | officer: CBO, Treasurer & Secretary | 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Lawrence M Alleva | director | 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451 |
Scott D Sandell | 10 percent owner |
From GuruFocus
By PRNewswire • 07-17-2023
By PRNewswire • 06-27-2023
By Marketwired • 09-06-2023
By Marketwired • 07-27-2023
By Marketwired • 07-19-2023
By PRNewswire • 06-23-2023
By Marketwired • 07-24-2023
By PRNewswire • 06-26-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.